PlainRecalls
FDA Drug Moderate Class II Terminated

Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.

Reported: December 7, 2016 Initiated: October 28, 2016 #D-0165-2017

Product Description

Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.

Reason for Recall

CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.

Details

Units Affected
2,882,661 tablets
Distribution
Nationwide in USA and Puerto Rico
Location
Iselin, NJ

Frequently Asked Questions

What product was recalled?
Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.. Recalled by Nationwide Laboratories, LLC. Units affected: 2,882,661 tablets.
Why was this product recalled?
CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 7, 2016. Severity: Moderate. Recall number: D-0165-2017.